Search

Your search keyword '"Antibody Affinity immunology"' showing total 1,223 results

Search Constraints

Start Over You searched for: Descriptor "Antibody Affinity immunology" Remove constraint Descriptor: "Antibody Affinity immunology"
1,223 results on '"Antibody Affinity immunology"'

Search Results

1. Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies.

2. Quantity increase and functional affinity/avidity decrease of anti-FcεRI and anti-IgE autoantibodies in chronic spontaneous urticaria.

3. Conversion of vaccines from low to high immunogenicity by antibodies with epitope complementarity.

5. Rapid affinity optimization of an anti-TREM2 clinical lead antibody by cross-lineage immune repertoire mining.

6. Studying the Humoral Response against SARS-CoV-2 in Cuban COVID-19 Recovered Patients.

7. Determining the Degree of Sulfo-tag Conjugation to AAV5 Vectors by LC-HRMS and Evaluating the Effects on Antibody Binding Affinity and Bridging Assay Sensitivity.

8. Affinity-independent memory B cell origin of the early antibody-secreting cell response in naive individuals upon SARS-CoV-2 vaccination.

9. Avidity maturation of humoral response following primary and booster doses of BNT162b2 mRNA vaccine among nursing home residents and healthcare workers.

10. Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIV AD8-EO infection.

11. Affinity alone does not drive long-lived plasma cell differentiation.

12. TRIM21 and Fc-engineered antibodies: decoding its complex antibody binding mode with implications for viral neutralization.

13. HIV-related immune activation attenuates polyfunctional IgG and memory B-cell responses to Tdap immunization during pregnancy.

14. Affinity gaps among B cells in germinal centers drive the selection of MPER precursors.

15. In vivo affinity maturation of mouse B cells reprogrammed to express human antibodies.

16. A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability.

17. Measles IgG Avidity Assay.

18. Insight into the avidity-affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn.

19. Long-primed germinal centres with enduring affinity maturation and clonal migration.

20. Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern.

21. Autoreactive antibodies control blood glucose by regulating insulin homeostasis.

22. Impact of anti-PEG antibody affinity on accelerated blood clearance of pegylated epoetin beta in mice.

23. Model-based inference of neutralizing antibody avidities against influenza virus.

24. Engineering pan-HIV-1 neutralization potency through multispecific antibody avidity.

25. Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination.

26. A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies.

27. Structures of Two Human Astrovirus Capsid/Neutralizing Antibody Complexes Reveal Distinct Epitopes and Inhibition of Virus Attachment to Cells.

28. Quality comparability assessment of a SARS-CoV-2-neutralizing antibody across transient, mini-pool-derived and single-clone CHO cells.

29. An immunodominant NP 105-113 -B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease.

30. Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3.

31. EASINESS: E. coli Assisted Speedy affINity-maturation Evolution SyStem.

32. Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex.

33. Multiplexed, High-Sensitivity Measurements of Antibody Affinity Using Interferometric Reflectance Imaging Sensor.

34. Development of Neutralizing Multimeric Nanobody Constructs Directed against IL-13: From Immunization to Lead Optimization.

35. Antibody-guided design and identification of CD25-binding small antibody mimetics using mammalian cell surface display.

36. An integrated computational pipeline for designing high-affinity nanobodies with expanded genetic codes.

37. Conjugation of Zika virus EDIII with CRM 197 , 8-arm PEG and mannan for development of an effective Zika virus vaccine.

38. Rapid and Quantitative Detection of Human Antibodies against the 2019 Novel Coronavirus SARS CoV2 and Its Variants as a Result of Vaccination and Infection.

39. Biophysical Evaluation of Rhesus Macaque Fc Gamma Receptors Reveals Similar IgG Fc Glycoform Preferences to Human Receptors.

40. The interaction of anti-DNA antibodies with DNA antigen: Evidence for hysteresis for high avidity binding.

41. Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2.

42. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.

43. The unique biology of germinal center B cells.

44. Germinal center-dependent and -independent memory B cells produced throughout the immune response.

45. HLA Does Not Impact on Short-Medium-Term Antibody Response to Preventive Anti-SARS-Cov-2 Vaccine.

46. Biparatopic single-domain antibodies against Axl achieve ultra-high affinity through intramolecular engagement.

47. Tatibody, a recombinant antibody with higher internalization potency.

48. Immune evasion of SARS-CoV-2 variants of concern is driven by low affinity to neutralizing antibodies.

49. An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency.

50. Nanoscale spatial dependence of avidity in an IgG1 antibody.

Catalog

Books, media, physical & digital resources